FY 2019 Annual Report
The FY 2019 Annual Report shows how the OTC has been "Leading Through Partnerships" during the fiscal year 2019.
We want to thank the University of Kentucky research and Lexington communities for continuing to demonstrate our innovation capacity: there is more than you think, and there will be more than there is.
Innovation and commercialization activity in this last fiscal year remained unprecedented for moving UK innovations to market and setting new record highs for inventions (104), patents filed (85), and new licenses executed (30).
By The Numbers
104 inventions
disclosed in FY 2019
$2.35 million
in gross royalty income in FY 2019
26 patents
issued to UK in FY 2019
$5.61 million
in income distributed to inventors since 2010
30 licenses & options
active as of June 30, 2019
$15.72 million
income distributed to colleges & departments since 2010
NIGMS Grant Update
UK OTC, Partners Receive Phase II Funding for Southeast XLerator Network
In October 2018, it was announced that the University of Kentucky (UK) , as the academic lead partner with XLerateHealth , a health technology accelerator based in Louisville, and regional partners had received a federal National Institutes of Health (NIH) grant that could potentially total $3.5 million over three years to create a hub to accelerate the commercialization of biomedical technologies. This hub, one of four NIGMS IDeA Hubs, will benefit university innovators and their commercialization resource partners in the Southeast Institutional Development Award (IDeA) region (AR, KY, LA, MS, PR, SC, and WV).
After Phase I planning, OTC is pleased to announce that funding for Phase II was awarded. The award provides $1.49 million to execute on the Phase I planning. In addition, the Southeast XLerator Network was awarded an Administrative Supplement of $250,000 to fund the advancement of promising health technologies with commercial potential across the region, which the Hub has called the “Ideas to Products (I2P)” program.